搜索结果：Veterinary journal (London, England : 1997)

Following the isolation of previously unrecognised species of Brucella from stranded seals and cetaceans in Scotland and northern England, a serological survey was carried out to investigate the range of marine mammal species which may have been exposed to Brucella species around the coasts of England and Wales, the prevalence of infection and the temporal and geographical distribution of seropositive animals. Serum collected from 153 stranded marine mammals from the coasts of England and Wales between 1989 and 1995 were tested by competitive and indirect ELISA. Positive titres were recorded for six of 62 (10 per cent) grey seals (Halichoerus grypus), one of 12 (8 per cent) common seals (Phoca vitulina), 11 of 35 (31 per cent) harbour porpoises (Phocoena phocoena) and nine of 29 (31 per cent) common dolphins (Delphinus delphis) tested. Positive titres were also found in a striped dolphin (Stenella coeruleoalba), a bottlenose dolphin (Tursiops truncatus), a killer whale (Orcinus orca) and a pilot whale (Globicephala melas). The seropositive animals were from all around the coasts of England and Wales and the first seropositive sample was from a common dolphin in 1990.

Nucleos/tide analogue (NA) drugs are used for long-term treatment of chronic hepatitis B virus (HBV) infection, with treatment eligibility criteria changing rapidly amidst globally evolving clinical guidelines. We aimed to quantify the prescription of NA drugs to date, and to undertake a preliminary assessment of the impact of relaxing treatment eligibility thresholds, leveraging a unique large real-world secondary care dataset. We assimilated longitudinal clinical data, collected between February 1997 and April 2023 from adults with chronic HBV infection from six centres in England through the UK NIHR Health Informatics Collaborative (HIC) Viral Hepatitis and Liver Disease theme. We describe factors currently associated with the receipt of NA treatment and determine the proportion of the population who would become treatment eligible as thresholds change. Across 7558 adults with a mean follow-up of 4.0 years (SD 3.9), NA treatment was prescribed in 2014/7558 (26.6%), and as expected according to guidelines at the time, was associated with HBV e-antigen (HBeAg) positivity and alanine transferase (ALT) above the upper limit of normal (> ULN). Treatment was more likely in males, older adults, in Asian and Other ethnicities (compared to White), and less likely in socioeconomically deprived individuals. The proportion of treatment-eligible individuals was 32.3% based on 2 records of ALT > ULN over 6-12 months, 41.7% based on ALT > ULN and viral load (VL) > 2000 IU/mL, and 95.1% based on detectable VL and either ALT > ULN or age > 30 years. Evolving clinical guidelines will lead to substantial increases in the proportion of individuals living with HBV who are eligible for treatment, underlining the need for services to adapt rapidly to the changing clinical environment.

Methicillin-resistant Staphylococcus aureus (MRSA) represents a significant public health challenge. In New Zealand, the community-associated MRSA sequence type (ST)5, carrying the staphylococcal cassette chromosome mec (SCCmec) type IV genetic element (which confers methicillin resistance), has been predominant since its detection in 2005. Known informally as the AK3 strain, it also exhibits resistance to fusidic acid. Here, we investigated the genomic evolution of the AK3 strain by analysing 397 genomes, comprising 361 MRSA and 36 closely related methicillin-susceptible S. aureus (MSSA) genomes, including 285 recently sequenced isolates from New Zealand spanning 2020 (n=30), 2021 (n=77), 2022 (n=88), 2023 (n=73) and 2024 (n=17). Phylogenetic analysis revealed that the AK3 strain evolved through stepwise acquisition of mobile genetic elements, with an MSSA ancestor likely introduced to New Zealand in the late 1970s. The lineage first acquired a SaPITokyo12571-like pathogenicity island, which contains the staphylococcal enterotoxin C bovine variant (sec-bov) and an enterotoxin-like protein (sel), between 1984 and 1991. This was followed by the integration of SCCmec type IV and adjacent fusidic acid resistance operon between 1997 and 2000. This timing coincides with increased community fusidic acid use in New Zealand. The AK3 strain then diversified into three major clades, spreading throughout New Zealand and Australia, with sporadic detection in European countries and Samoa. Our findings demonstrate how the sequential acquisition of mobile genetic elements, combined with antibiotic selection pressure, likely contributed to the successful emergence of AK3 and its spread in the South Pacific region.

Effective mucosal immunity in the intestine involves a fine balance between tolerance of the microbiome, recognition, and elimination of pathogens, and inflammatory tissue injury. The anti-inflammatory cytokine IL10 regulates these processes in the intestines of mice and humans; the anti-inflammatory activity of IL10 is also conserved in birds. To determine the function of IL10 in avian mucosal immunity, we generated germ line modifications of the chicken IL10 locus to abolish or reduce IL10 expression. In vitro analysis of macrophage response to lipopolysaccharide confirmed the loss of IL10 protein expression, the lack of dosage compensation in heterozygotes, and prevention of autocrine inhibition of nitric oxide production in homozygous IL10 knockout macrophages. IL10-deficiency significantly altered the composition of the caecal microbiome, but unlike IL10-deficient mice and humans, IL10-deficient chickens did not exhibit spontaneous colitis. Following experimental challenge with Salmonella enterica serovar Typhimurium or Campylobacter jejuni in IL10-deficient chickens, enhanced clearance of the pathogens was associated with elevated transcription of pro-inflammatory genes and increased infiltration of inflammatory cells into gut mucosa. In IL10-deficient chickens challenged with the parasite Eimeria tenella, pathogen clearance was accelerated but caecal lesions were more severe and weight gain was compromised. Neither the heterozygous IL10 knockout nor a homozygous IL10 enhancer mutation had a major effect on pathogen clearance or inflammation in any of the challenge models. Our findings highlight the intrinsic compromise in mucosal immune response and have important implications for the development of strategies to combat avian and zoonotic pathogens in poultry.

The incidence of multiple drug resistance (to four or more antimicrobials) in salmonellas from humans in England and Wales in 1996 has been compared with corresponding data for 1994. For Salmonella enteritidis multiple resistance has remained rare, although a high proportion of isolates of phage type 6A have shown resistance to ampicillin. For S. typhimurium multiple resistance has continued to increase, with 81% of isolates now multiresistant. Of particular importance in S. typhimurium has been the continued epidemic of multiresistant DT 104 and the increasing occurrence of strains of this phage type with additional resistance to trimethoprim and/or ciprofloxacin. For S. virchow, a 10% increase in multiple resistance is mainly concentrated in two phage types common in returning travellers. For S. hadar, there has been a substantial increase in the incidence of multiple resistance with over 50% of isolates now multiresistant. Substantial increases in the incidence of resistance to ciprofloxacin in multiresistant S. typhimurium DT 104, S. virchow, and S. hadar since 1993, when the fluoroquinolone antibiotic enrofloxacin was licensed for veterinary use in the UK, are of particular concern.

To test the sensitivity of strains of Campylobacter species isolated from humans in England and Wales against a range of antimicrobial agents for the purpose of monitoring therapeutic efficacy and as an epidemiological marker. An agar dilution breakpoint technique was used to screen isolates against ampicillin, chloramphenicol, gentamicin, kanamycin, neomycin, tetracycline, nalidixic acid, ciprofloxacin, and erythromycin. Minimal inhibitory concentrations (MIC) were also determined for a sample of quinolone resistant strains. Approximately 50% of strains tested were resistant to at least one drug. Strains which were resistant to four or more of the drugs tested were classified as multiresistant; this occurred in 11.3% of C jejuni, 19.9% of C coli, and 63.6% of C lari. Resistance to erythromycin occurred in 1.0% of C jejuni and 12.8% of C coli. Resistance to quinolones occurred in 12% of strains, with a ciprofloxacin MIC of > 8 mg/l and a nalidixic acid MIC of > 256 mg/l; a further 4% of strains had intermediate resistance with a ciprofloxacin MIC of between 0.5 and 2 mg/l (fully sensitive strains, 0.25 mg/l or less) and a nalidixic acid MIC of between 32 and 64 mg/l (fully sensitive strains, 8 mg/l or less). Resistance to quinolones in campylobacters from human infection may relate to clinical overuse or use of fluoroquinolones in animal husbandry. Both veterinary and clinical use should be reconsidered and fluoroquinolone drugs used only as a treatment for serious infections requiring hospital admission. Erythromycin resistance is still rare in C jejuni but much more common in C coli.

暂无摘要（点击查看详情）

A retrospective study of laminitis was carried out to identify risk factors associated with this disease on an East Anglian farm with approximately 1000 animals living in an area of 1000 acres. Medical records between January 1997 and May 2000 and between April 2005 and March 2008 were reviewed, and the age, sex, weight (kg), height (inches [in] and hands [H]) and weight-to-height ratio (kg/in) was recorded. The prevalence, incidence and seasonality of laminitis were determined and their relationship to the monthly temperature, rainfall and hours of sunshine was evaluated. Averaged over the six years, the highest prevalence (2.6 per cent) and incidence (16 cases/1000 animals) of laminitis occurred in May. The findings of a multivariate analysis revealed that females (P=0.007, odds ratio [OR] 1.46, 95 per cent confidence interval [CI] 1.1053 to 1.9646) and light animals (P ≤ 0.001, OR=0.995, 95 per cent CI =0.9932 to 0.9963) had the greatest risk of developing laminitis. A positive association was found between hours of sunshine and incidence (P=0.007, relative risk [RR] 1.009, 95 per cent CI 1.001 to 1.012) and prevalence (P=0.002, RR 1.008, 95 per cent CI 1.003 to 1.012) of laminitis. The data suggest that there is a relationship between season, sex of the animal and the development of laminitis.

G3 rotaviruses rank among the most common rotavirus strains worldwide in humans and animals. However, despite a robust long-term rotavirus surveillance system from 1997 at Queen Elizabeth Central Hospital in Blantyre, Malawi, these strains were only detected from 1997 to 1999 and then disappeared and re-emerged in 2017, 5 years after the introduction of the Rotarix rotavirus vaccine. Here, we analysed representative twenty-seven whole genome sequences (G3P[4], n = 20; G3P[6], n = 1; and G3P[8], n = 6) randomly selected each month between November 2017 and August 2019 to understand how G3 strains re-emerged in Malawi. We found four genotype constellations that were associated with the emergent G3 strains and co-circulated in Malawi post-Rotarix vaccine introduction: G3P[4] and G3P[6] strains with the DS-1-like genetic backbone genes (G3-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2 and G3-P[6]-I2-R2-C2-M2-A2-N2-T2-E2-H2), G3P[8] strains with the Wa-like genetic backbone genes (G3-P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1), and reassortant G3P[4] strains consisting of the DS-1-like genetic backbone genes and a Wa-like NSP2 (N1) gene (G3-P[4]-I2-R2-C2-M2-A2-N1-T2-E2-H2). Time-resolved phylogenetic trees demonstrated that the most recent common ancestor for each ribonucleic acid (RNA) segment of the emergent G3 strains was between 1996 and 2012, possibly through introductions from outside the country due to the limited genetic similarity with G3 strains which circulated before their disappearance in the late 1990s. Further genomic analysis revealed that the reassortant DS-1-like G3P[4] strains acquired a Wa-like NSP2 genome segment (N1 genotype) through intergenogroup reassortment; an artiodactyl-like VP3 through intergenogroup interspecies reassortment; and VP6, NSP1, and NSP4 segments through intragenogroup reassortment likely before importation into Malawi. Additionally, the emergent G3 strains contain amino acid substitutions within the antigenic regions of the VP4 proteins which could potentially impact the binding of rotavirus vaccine-induced antibodies. Altogether, our findings show that multiple strains with either Wa-like or DS-1-like genotype constellations have driven the re-emergence of G3 strains. The findings also highlight the role of human mobility and genome reassortment events in the cross-border dissemination and evolution of rotavirus strains in Malawi necessitating the need for long-term genomic surveillance of rotavirus in high disease-burden settings to inform disease prevention and control.

We investigated the transmission dynamics of lyssavirus in Myotis myotis and Myotis blythii, using serological, virological, demographic and ecological data collected between 2015 and 2022 from two maternity colonies in northern Italian churches. Despite no lyssavirus detection in 556 bats sampled over 11 events by reverse transcription-polymerase chain reaction (RT-PCR), 36.3% of 837 bats sampled over 27 events showed neutralizing antibodies to European bat lyssavirus 1, with a significant increase in summers. By fitting sets of mechanistic models to seroprevalence data, we investigated factors that influenced lyssavirus transmission within and between years. Five models were selected as a group of final models: in one model, a proportion of exposed bats (median model estimate: 5.8%) became infectious and died while the other exposed bats recovered with immunity without becoming infectious; in the other four models, all exposed bats became infectious and recovered with immunity. The final models supported that the two colonies experienced seasonal outbreaks driven by: (i) immunity loss particularly during hibernation, (ii) density-dependent transmission, and (iii) a high transmission rate after synchronous birthing. These findings highlight the importance of understanding ecological factors, including colony size and synchronous birthing timing, and potential infection heterogeneities to enable more robust assessments of lyssavirus spillover risk.

Abstract  The pathogenesis of wound infections is largely dependent on adherence mechanisms and toxins. Studies of Staphylococcus intermedins indicate that pyoderma isolates can bind to extracellular matrix proteins exposed in wounds but interpretation of adherence studies is complicated as some organisms possess multiple mechanisms. Studies of blocking and promotion of adherence by antibiotics also show variability. Epidermolytic toxins are recognized in S. aureus and S. hyicus but not in S. intermedins, although a synergohymenotropic toxin has been described and canine syndromes occur where epidermal splitting and S. intermedins infection co-exist. Staphylococcal enterotoxins and toxic shock toxin-1 are recognized as superantigens which cause cytokine release non-specifically, promoting inflammation in wounds. Treatment of infected skin depends largely on antibiotics but drug resistance will limit this; a move towards vaccines and re-examination of the value of antisepsis is occurring. Use of dressings which reduce microbial growth must also be a factor in wound management. Resumen  La patogenesis de las infecciones de heridas depende en gran medida de los mecanismos de adherencia y de las toxinas. Algunos estudios en Staphylococcus intermedius indican que los aislamientos a partir de áreas de pioderma pueden adherirse a proteinas de la matriz extracelular expuesta en las heridas aunque la interpretación de estudios de adherencia es complicado ya que algunos organismos poseen múltiples mecanismos. Los estudios con antibióticos sobre su capacidad de bloqueo y promoción de la adherencia también muestran variabilidad. Se reconocen toxinas epidermolíticas en S. aureus y S. hyicus pero no en S. intermedius, aunque se ha descrito una toxina sinergohimenotrópica y se producen sindromes caninos en áreas de coexistencia de rotura epidérmica y S. intermedius. Las enterotoxinas estafilocócicas y la Toxina-1 de Shock Tóxico son reconocidas como superantígenos que causan liberación inespecífica de citoquinas, promoviendo la inflamación a nivel de las heridas. El tratamiento de la piel infectada depende en gran medida de los antibióticos, aunque esto se encuentra limitado por las resistencias; se está tendiendo a las vacunaciones y a una re-evaluación del valor de la antisepsia. El uso de vendas que reduzcan el crecimiento bacteriano deberia también ser un factor en el manejo de heridas. [Noble, W.C., Lloyd, D.H. Pathogenesis and management of wound infections in domestic animals (Patogenesis y manejo de heridas infectadas en animales domesticos). Veterinary Dermatology 1997; 8: 243-248] Zusammenfassung  Die Pathogenese von Wundinfektionen hängt hauptsächlich von Haftungsmechanismen und Toxinen ab. Studien von Staphylokokkus intermedius weisen nach, dass Isolate von Pyodermien sich an in Wunden exponierte extrazelluläre Matrixproteine binden; die Interpretation dieser Haftungsstudien wird durch multiple Mechanismen einiger Organismen kompliziert. Studien, diese Haftung durch Antibiotika zu blockieren oder zu fördern, zeigen variable Ergebnisse. Epidermolytische Toxine sind für S. aureus und S. hyicus, aber nicht für S. intermedius beschrieben, obwohl von einem synergohymenotropischen Toxin berichtet wird und beim Hund Syndrome auftreten, in denen epidermale Spaltung und S. intermedius Infektion koexistieren. Enterotoxine und Toxischer Schock Toxin 1 von Staphylokokkus werden als Superantigene anerkannt, die nicht spezifische Zytokinfreisetzung verursachen und so die Entzündung in Wunden fördern. Die Behandlung infizierter Haut erfolgt weitgehend durch Antibiotika, aber Resistenzbildung wird deren Verwendung einschränken; im Moment geht die Tendenz mehr in Richtung Impfungen und die Neubewertung von Antisepsis. Die Verwendung von Verbandsmaterialien, die das Wachstum von Mikroorganismen einschränken, muss in der Wundversorgung berücksichtigt werden. [Noble, W.C., Lloyd, D.H. Pathogenesis and management of wound infections in domestic animals (Pathogenese und Versorgung von Wundinfektionen bei Haustieren). Veterinary Dermatology 1997; 8: 243-248] Résumé  La pathogénie des plaies infectées dépend largement de mécanismes d'adhérence et de toxines. L'étude de Staphylococcus intermedius montre que des germes de pyodermite peuvent adhérer aux protéines des matrices extracellulaires mises à nu par des blessures mais l'interprétation des études d'adhérence est compliquée par le fait que certains germes possèdent de multiples mécanismes. Des études d'inhibition ou d'activation d'adhérence par des antibiotiques démontrent également une variabilité. On connait l'existence de toxines épidermolytiques chez S. aureus et S. hyicus mais pas chez S. intermedius, bien qu'une toxine synergohymenotropique ait été décrite, et que des syndrômes où clivage épidermique et infection àStaphylococcus intermedius coexistent aient été décrit chez le chien. II est admis que des entérotoxines staphylococciques et la toxine 1 du choc toxique agissent comme des superantigènes qui provoquent une libération non spécifique de cytokines, provoquant l'inflammation des plaies. Le traitement des plaies infectées dépend largement des antibiotiques mais est limité par le phénomène d'antibiorésistance; actuellement, une tendance à reconsidérer la valeur des vaccins et de l'antisepsie se dessine. L'utilisation de pansements qui réduisent la prolifération bactérienne peut également être un facteur du traitement des plaies. [Noble, W.C., Lloyd, D.H. Pathogenesis and management of wound infections in domestic animals (Pathogénie et traitement des plaies infectées chez les animaux domestiques). Veterinary Dermatology 1997; 8: 243-248].

Abstract  Understanding of the processes involved in wound healing in vertebrates is increasing rapidly owing to the application of advances in cell and molecular biology, and in technology. The cellular mechanisms which result in some vertebrates having the ability to regenerate the dermis after injury, whereas in others it is replaced by scar tissue, are currently being explored with a view to restoring this regenerative ability by modulating the intercellular systems which control wound healing. This introductory review (a) compares and contrasts the response to injury of homoiofhermic and poikilothermic animals and of foetal and post-natal mammals; (b) describes the mechanisms involved in cutaneous wound healing; (c) illustrates how the rate and quality of healing can be assessed non-invasively and objectively, and (d) describes how cutaneous healing can be improved by the application of electrophysical modalities employing ultrasound and light. Zusammenfassung  Unser Verständnis von Wundheilungsprozessen bei Wirbeltieren wächst wegen der Fortschritte in Zell- und Molekularbiologie und Technologie rapide. Die zellulären Mechanismen, die es einigen Wirbeltieren ermöglichen, die Haut nach einer Verletzung zu regenerieren, während sie bei anderen durch Narbengewebe ersetzt wird, werden gegenwärtig erforscht, um diese Regenerationsfähigkeit durch Veränderung der interzellulären Systeme, die die Wundheilung kontrollieren, wiederherzustellen. Diese einführende Übersicht (a) vergleicht die Reaktion auf Verletzung in homiothermischen und poikilothermischen Tieren und in Säugetierfeten und Säugetieren nach der Geburt; (b) beschreibt die Mechanismen der kutanen Wundheilung; (c) illustriert, wie die Heilungsrate und -fähigkeit nichtinvasiv und objektiv bewertet werden kann, und (d) beschreibt, wie Wundheilung durch die Anwendung von elektrophysikalischen Heilmitteln wie Ultraschall und Licht verbessert werden kann. [Dyson, M. Advances in wound healing physiology: the comparative perspective (Fortschritte in der Wundheilungsphysiologie: die vergleichende Perspektive). Veterinary Dermatology 1997; 8: 227-233] Resumé  La compréhension des processus impliqués dans la cicatrisation des plaies chez les vertébrés croït rapidement suite à l'application des progrès en biologie cellulaire et moléculaire et en technologie. Les mécanismes cellulaires qui résultent chez certains vertébrés dans la capacité du derme à se régénérer après une blessure alors que chez d'autres, il est remplacé par du tissus cicatriciel, sont actuellement explorés avec pour but de restaurer cette capacité régénératrice en modulant les systèmes intercellulaires qui contrôlent la cicatrisation des plaies. Cette revue d'introduction (a) compare et contraste la réponse des animaux homoiothermiques et poikilothermiques et des mammifères foetaux et postnataux au traumatisme; (b) décrit les mécanismes impliqués dans la cicatrisation des plaies; (c) illustre comment le taux et la qualité de cicatrisation peuvent être évalués de manière non invasive et objective; et (d) décrit comment la cicatrisation cutanée peut être améliorée par l'application de modalités électrophysiques utilisant ultra sons et lumière. [Dyson, M. Advances in wound healing physiology: the comparative perspective (Progres de la physiologie de la cicatrisation des plaies: les perspectives comparatives). Veterinary Dermatology 1997; 8: 227-233] Resumen  El conocimiento de los procesos implicados en la curación de heridas en los vertebrados aumenta rápidamente debido a la aplicación de avances en biologia celular y molecular, y a la tecnologia. Actualmente se estan estudiando los mecanismos celulares que hacen que algunos vertebrados tengan la capacidad de regenerar la dermis después de una herida, mientras que en otros se sustituye por tejido de cicatrización, con el objetivo de restaurar la capacidad regenerativa modulando los sistemas intercelulares que controlan la curación de heridas. Esta revision introductoria a) compara y contrasta la respuesta a las heridas en animales homoiotermos y poiquilotermos y en mamiferos fetales y post-natales; b) describe los mecanismos implicados en la curación de heridas cutáneas; c) ilustra cómo el ritmo y la calidad de curación puede ser monitorizado de forma no-invasiva y objetiva y d) describe como la curación cutánea mejora mediante la aplicación de modalidades electrofisicas utilizando ultrasonidos y luz. [Dyson, M. Advances in wound healing physiology: the comparative perspective (Avances en fisiologia de la curación de heridas: perspectiva). Veterinary Dermatology 1997; 8: 227-233].

Embryo splitting or twinning has been widely used in veterinary medicine over 20 years to generate monozygotic twins with desirable genetic characteristics. The first human embryo splitting, reported in 1993, triggered fierce ethical debate on human embryo cloning. Since Dolly the sheep was born in 1997, the international community has acknowledged the complexity of the moral arguments related to this research and has expressed concerns about the potential for reproductive cloning in humans. A number of countries have formulated bans either through laws, decrees or official statements. However, in general, these laws specifically define cloning as an embryo that is generated via nuclear transfer (NT) and do not mention embryo splitting. Only the UK includes under cloning both embryo splitting and NT in the same legislation. On the contrary, the Ethics Committee of the American Society for Reproductive Medicine does not have a major ethical objection to transferring two or more artificially created embryos with the same genome with the aim of producing a single pregnancy, stating that 'since embryo splitting has the potential to improve the efficacy of IVF treatments for infertility, research to investigate the technique is ethically acceptable'. Embryo splitting has been introduced successfully to the veterinary medicine several decades ago and today is a part of standard practice. We present here an overview of embryo splitting experiments in humans and non-human primates and discuss the potential of this technology in assisted reproduction and research. A comprehensive literature search was carried out using PUBMED and Google Scholar databases to identify studies on embryo splitting in humans and non-human primates. 'Embryo splitting' and 'embryo twinning' were used as the keywords, alone or in combination with other search phrases relevant to the topics of biology of preimplantation embryos. A very limited number of studies have been conducted in humans and non-human primates. The published material, especially the studies with human embryos, is controversial. Some reports suggest that twinning technology will find clinical use in reproductive medicine in the future, whereas others conclude the opposite that human twin embryos created in vitro are unsuitable not only for clinical, but also for research, purposes. The blastomere biopsy technique of embryo splitting seems to be unsuitable for either clinical or research purposes; however, embryo bisection, a preferable method of cloning in veterinary medicine, has not yet been tested on human embryos.

In 1969, the Swann Committee reported that there was a significant problem with regard to antimicrobial (mis)use in both human and veterinary practice and recommended that the UK Government establish a committee that should have overall responsibility for the whole field of antimicrobial use. This view was reiterated in 1997-8 by the House of Lords Science and Technology Committee, under the Chairmanship of Lord Soulsby of Swaffham Prior. In 2001 such a group, the Specialist Advisory Committee on Antimicrobial Resistance (SACAR), was finally launched. SACAR encompassed representatives from human and veterinary medicine and involved many branches of public health, pharmacy, nursing, bacteriology and virology. It met three times a year and has advised ministers and the Chief Medical Officer on current and emerging problems by providing expert advice to inform local and national policy on antimicrobial resistance. This Supplement provides an overview of the work of SACAR and its Subgroups.

Infectious disease is a significant driver of global amphibian declines, yet despite this, relatively little is known about the range of pathogens that affect free-living amphibians. Recent detection of the tentatively named Ranid herpesvirus 3 (RHV3), associated with skin disease in free-living common frogs Rana temporaria in Switzerland, helps to address this paucity in knowledge, but the geographic distribution and epidemiology of the pathogen remains unclear. Syndromic surveillance for ranid herpesvirus skin disease was undertaken throughout Great Britain (GB), January 2014 to December 2016. Reports of common frogs with macroscopic skin lesions with a characteristic grey appearance were solicited from members of the public. Post-mortem examination was conducted on one affected frog found dead in 2015 at a site in England. In addition, archived samples from an incident involving common frogs in England in 1997 with similar macroscopic lesions were further investigated. Transmission electron microscopy identified herpes-like virions in skin lesions from both the 1997 and 2015 incidents. RHV3, or RHV3-like virus, was detected in skin lesions from the 2015 case by PCR and sequencing. Our findings indicate that herpesvirus skin disease is endemic in common frogs in GB, with widespread distribution at apparently low prevalence. Further research into the role of host immunity, virus latency and the significance of infection to host survival is required to better understand the epidemiology and impact of cutaneous herpesvirus infections in amphibian populations.

The results of a serological survey of livestock in Kazakhstan, carried out in 1997--1998, are reported. Serum samples from 958 animals (cattle, sheep and goats) were tested for antibodies to foot and mouth disease (FMD), bluetongue (BT), epizootic haemorrhagic disease (EHD), rinderpest (RP) and peste des petits ruminants (PPR) viruses, and to Brucella spp. We also investigated the vaccination status of livestock and related this to changes in veterinary provision since independence in 1991. For the 2 diseases under official surveillance (FMD and brucellosis) our results were similar to official data, although we found significantly higher brucellosis levels in 2 districts and widespread ignorance about FMD vaccination status. The seroprevalence for BT virus was 23%, and seropositive animals were widespread suggesting endemicity, despite the disease not having being previously reported. We found a few seropositives for EHDV and PPRV, which may suggest that these diseases are also present in Kazakhstan. An hierarchical model showed that seroprevalence to FMD and BT viruses were clustered at the farm/village level, rather than at a larger spatial scale. This was unexpected for FMD, which is subject to vaccination policies which vary at the raion (county) level.

Adult females of the blood-sucking muscid Stomoxys calcitrans sampled between June and September 1993 from a cattle farm (n = 839) and from a pig farm (n = 542) in North-West England were examined for mites. Twelve species of mites from ten families and three orders were identified as follows. In the Prostigmata, Eryenetes sp., Family Ereynetidae and Pediculaster mesembrinae, Family Pygmephoridae. In the Astigmata, Procalvolia zacheri Family Saproglyphidae, Acarus farris, Family Acaridae, Bonomoia sphaerocerae and Myianoetus sp., Family Anoetidae. In the Mesostigmata, Macrocheles muscaedomesticae and Macrocheles subbadius Family Macrochelidae, Digamasellus sp., Family Digamasellidae, Halolaelaps sp., Family Halolaelapidae. Prodinychus sp., Family Uropodoidea and Thinoseius sp., Family Eviphididae. Mean infestation rates at the two sites (all mite species) for the entire sampling period were 31.6 +/- 13.9% and 19.8 +/- 3.6% respectively. 51% of synbovine flies sampled in July were infested with mites. Mean numbers of flies infested in August at both farms were significantly lower compared to other months. The presence of tritonymphs of Ereynetes sp. on S. calcitrans demonstrates for the first time that this life cycle stage is naturally associated with insects in the field. All mites were recovered from the ventral thorax and abdomen, and two or more species commonly infested individual flies. Associations of mites with their dipteran hosts are described and discussed.

The Independent Scientific Group on Cattle TB was appointed by the Government in 1998 to implement and develop the research recommendations of the 1997 Krebs report on bovine tuberculosis in cattle and badgers. In this article, members of the group discuss the approach they are adopting in attempting to ensure that future control strategies are scientifically based. In a second article, to be published in next week's Veterinary Record, the group will consider the extent to which efforts to control the disease in cattle may be constrained by limitations in current testing procedures.

Amphibians occupy a wide range of habitat types from arid deserts to deep freshwater lakes; they may spend most of their life underground or high in cloud forest canopy. Some are found north of the Arctic Circle and can tolerate freezing conditions, while others have evolved a range of adaptations to avoid desiccation in some of the hotter areas of the world. The skin plays key roles in the everyday survival of amphibians and their ability to exploit a wide range of habitats and ecological conditions. The normal functions of the skin are surveyed and Eisner's biorational approach to chemical prospecting--seeking clues from an animal's behaviour and its interactions with its environment to reveal the presence of chemical compounds with potential medical or veterinary applications--is applied to amphibians. The biology and natural history of amphibian skin, its glands and their secretions are briefly reviewed. Four categories of compounds are found in the granular or poison glands, these are: biogenic amines, bufodienolides (bufogenins), alkaloids and steroids, peptides and proteins. Toads, particularly members of the genus Bufo, are identified as a particularly convenient and useful source of granular gland secretions. The potential medical-pharmaceutical significance of products derived from amphibian skin secretions is discussed. The need for a humane approach to this work is noted.